Table 1.
Name |
Sequence |
Residues |
Net Charge[a] |
GRAVY[b] |
Species |
PTMs |
Antibacterial[c] |
Hemolytic |
---|---|---|---|---|---|---|---|---|
MAADIISTIGDLVKWIIDTVNKFK |
24 |
0 |
0.58 |
S. epidermidis |
– |
+ |
+ |
|
MLVTLSAMLQFGIFLIAFIGLVIDLIKLSQKK |
32 |
+2 |
1.65 |
S. aureus |
– |
+ |
+ |
|
Ascaphin‐6 [74] |
MGFKDWIKGAAKKLIKTVASSIANE |
25 |
+3 |
−0.10 |
A. truei |
– |
+ |
– |
Cecropin P1 [75] |
SWLSKTAKKLENSAKKRISEGIAIAIQGGPR |
31 |
+5 |
−0.56 |
A. suum |
– |
+ |
– |
Oxyopinin 2 b [76] |
MSYIPCGESCVYIPCTVTALLGCSCSNKVCYKN |
33 |
+7 |
−0.46 |
O. kitabensis |
– |
+ |
+ |
Meucin‐25 [77] |
MVKLIQIRIWIQYVTVLQMFSMKTKQ |
26 |
+4 |
0.40 |
M. eupeus |
– |
– |
– |
Cathelicidin‐BF [78] |
KRFKKFFKKLKKSVKKRAKKFFKKPRVIGVSIPF |
34 |
+16 |
−0.75 |
B. fasciatus |
– |
+ |
– |
[a] At pH=7. [b] Grand average of hydropathicity index (GRAVY), calculated as the average Kyte and Doolitle hydropathy index of each residue over the full sequence. [c] Against Gram‐negative bacteria.